Mr. Atin TomarPresident & CEO
Atin brings with him comprehensive experience in Biotechnology industry in the areas of Vaccines and Biologics, globally. Atin's expertise spans from Process Development, Scale-up, Technology Transfer and Manufacturing Operations to Business Development, Licensing and Commercialization.
Prior to joining CPL Biologicals, Atin was associated with the Biotechnology industry in various roles. He was involved in the development of Biologics/Bio-therapeutics from the early stages of development to commercial manufacturing at Human Genome Sciences Inc., Amgen Inc. and Syngene International Limited (A Biocon Company). At Dr. Reddy's Laboratories Ltd., MSD Wellcome Trust Hilleman Laboratories Pvt. Ltd. and International Vaccine Institute (IVI) Atin was involved in Business Development & Licensing, Partnerships and Collaborations, Program Management, Alliance Management and Commercialization for Biosimilars and Vaccines.
Atin completed his B.Tech (Hons) in Biotechnology and Biochemical Engineering from the Indian Institute of Technology (IIT) Kharagpur, India, MS in Biological Engineering from the University of Georgia, Athens, USA and Post-Graduate Programme in Management (MBA) in Finance and Strategy & Leadership from the Indian School of Business (ISB), Hyderabad, India.
Dr. Nirav DesaiVice President - R&D
Nirav is Biotech research professional with >18 years of industrial research experience in advancing Vaccines, Biologics and Diagnostic from PoC to commercialization. He has expertise in innovations, setting up PoC, process development, method development, technology transfer, facility start-up, and CRAMS management. Nirav is experienced in all aspects of technical operations including large-scale bioreactor operations, downstream process and analytical development. He has been responsible for development of innovative cancer vaccines and immunomodulators.and is currently developing Baculovirus-Sf9 system based Novel vaccines for Influenza, Rabies, EBOLA, MERS and Zika.
Nirav completed his B.S.(Hons) in Microbiology and Biotechnology from the Mumbai University, INDIA; M.S. (MSc) in Medical technology with Clinical Biochemistry from Narmad University, Surat, INDIA and PhD in Life sciences from Ahmedabad University, INDIA.
Mr. Ravinder SinghVice President - Manufacturing
Ravinder brings with him rich experience in Manufacturing Operations of Biotechnology industry in the areas of Vaccines and Biologics. Ravinder expertise spans from manufacturing Operations like Fermentation, Cell Culture, Process Development, Scale-up, Technology Transfer, validations to Supply Chain Management and Regulatory audits for product registration.
Prior to joining CPL Biologicals, Ravinder was associated with the Biotechnology industry in various roles. He was involved in the Green field projects for setting up new vaccine manufacturing facility and also Brown field projects for the capacity enhancement of existing vaccine Manufacturing facilities. Ravinder had wide ranging experience at different roles and at different positions in Bharat Immunological & Biological Corporation Ltd. UP, Human Biological Institute, Hyderabad and Panacea Biotec Ltd., Delhi.
Ravinder completed his M.Sc. (Hons.) in Biophysics from Biophysics Department, Panjab University, Chandigarh, India.
Mr. Pradeep KumarGeneral Manager - Sales and Marketing
Pradeep Kumar is a Sales & Marketing Professional with our 25+ years of experience in Sales & Strategic Business Development across India. Previously, Pradeep has worked for Organizations like Chiron (Novartis JV) & Panacea Biotec and brings with him 15 years of experience in marketing Vaccines.
Through the experience of handling different roles & responsibilities, Pradeep has developed deep expertise in devising Market Specific Strategies, Execution Excellence, Team Engagement & Development, Customer collaborations, Development of Key Opinion Leaders & Key Business Leaders.
Dr. Arun MaseehVice President - Medical Affairs
DR ARUN MASEEH has been in the Pharmaceutical Industry for more than 18 years and currently serves as Vice President CRO and as Cluster Head of Innovation (Clinical stage of small molecule and Biotechnology Product Development) at Cadila Pharmaceuticals Limited. He has played a key role in the team that developed IV Rabeprazole and the Polycap. Dr Maseeh trained at the Christian Medical College, CMC Vellore, where as a third year Medical Student, he conducted the study and presented papers on his identification of Drug Interactions between Cypraheptadine and Alfa-Methyl Dopa. At CMC Ludhiana, where he did his MD in Medicine, his study on â€œIdentification of Stunned Mycocardium using Dobutamine Stress Echocardiography (DSE)â€ was presented at the Cardiological Society of India Conference at Kolkatta in 1997.
Dr Maseeh has been associated with projects such as Hyaluronic acid, Erythropoietin, H1N1 vaccine, Influenza vaccine, Rabies Vaccine, Peg-GCSF etc. Dr Maseeh has a large number of oral and poster presentations at most of the global conferences in GI, Cancer, Cardiology and Respiratory Medicine, including :
Digestive Disease Week, [DDW] 2005, DDW 2006, United European
Gastroenterology Week [UEGW] 2004, Australian Gastroenterology Week [AGW] 2004, Asia Pacific Digestive Week [APDW] 2003, APDW 2004, American Society of Clinical Oncology, [ASCO] 2005, and the Olympics of Gastroenterology, The World Congress of Gastroenterology [WCOG] 2006. His fifty odd articles have been published in top journals including Gut, Endoscopy, Journal of Clinical Oncology, Jl of Gastroenterology and Hepatology, et c. Dr Arun Maseeh played a key role in The Indian Polycap Study, where, inspired by a BMJ hypothesis on the concept of a hypothetical polypill, he developed a specific combination of ingredients and steered the clinical trial to establish the safety and efficacy and Marketing Authorization. This paper was the highlight at the American College of Cardiology, ACC at Orlando Florida, 2009, and was on the cover of the Lancet in April 2009, along with a plethora of citations and media coverage (BBC, CNN, ABC, Guardian, USA Today, etc). Dr Maseeh enjoys playing the piano and is a baritone Western Classical Opera singer with qualifications from Trinity College, London.